Trial intelligence / Profile preview

Tiotropium add-on crossover study in severe asthma

ChiCTR2000029249Phase 4Not yet recruiting

Sponsor
West China Hospital of Sichuan University
Start
Feb 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of tiotropium in severe asthma (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Lung function, Non-neuronal cholinergic system components and 2 more. Planned start Feb 2020; status: not yet recruiting.

02

Drugs

tiotropium
03

Conditions

severe asthma

Beyond the preview

Go deeper on ChiCTR2000029249.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000029249.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call